Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fully agree and all that will come with a successful trial, governments would be very eager to get their hand on supply I am sure.
With B becoming known in Europe it would be nice for investors there to be able to buy into IPIX, only an up listing would provide that opportunity for that vast majority of investors there.
That would be great to have a lot of investors from Europe entering. I have told many friends and colleagues about IPIX, problem is that very few brokers in Europe offers trading in US OTC stocks even though they are fully reporting on OTCQB or higher, there are no brokers offering trading in US pink sheets. very few offer trading in IPIX with none in the UK and only one broker in Denmark as far as I am aware and here you have to call in the order and the fee is fairly high. I don't believe it is most different in the rest of Europe, this is however based on search I did 3 years ago when I was looking for a European broker to trade OTC stocks through.
Up listing out of the OTC would open the doors to a lot of foreign investment from Europe, that should be Leo's next move after a successful trial IMO
Now around as an A.I system.
https://www.ask-socrates.com/
it is a paid subscription though
That would be a very smart move on Leo's part if he pursued trials in other countries, the recent addition from Sanofi might play a part here. Maybe a clinical trial in France?
Thanks Great find
Fully agree with all points, thanks
Another great post, thanks
Great post and fully agree. Thanks for taking the time to write it.
So there is one guy at the WHO with some sanity, good to see.
Good points.
They Have been voted the happiest people of Europe a few times, I don't know about the world though.
Pretty high, starts at 32% and goes up to 58% top tax on a progressive scale. Denmark slightly higher as the highest tax rate in the world as far as I am aware.
Well they did not have a mandatory lockdown, or mandatory facemasks, their guidelines were voluntary. I would say that differs significantly from most other countries. The Danes were going to Sweden all the time to enjoy restaurants and bars whilst Denmark was in lockdown.
I see Sweden is still doing well, they had 5800 deaths a few months ago and now up to 5894. looks like herd immunity is working fine there.
I thought it was a very fair and balanced article LOL
Great post and just highlights the insanity going on
Here is another article on Insiderfinancial. it is about the other treatments out there, but mostly about CytoDyn's Leronlimab and its struggle to get to market.
https://insiderfinancial.com/all-eyes-on-cytodyn-now-that-trump-has-covid-19/180495/
From the article.
There are only 3 COVID-19 leading therapeutics (Ampion, Tocilizumab, and Leronlimab) that are classified as shots. Ampion which is made by Ampio Pharmaceuticals (NASDAQ: AMPE) is currently classified as a shot but their COVID-19 product is likely to be via intravenous or a nebulizer. So they are a contender but Tocilizumab which is made by Roche Holding (OTCMKTS: RHHBY) failed to meet its endpoint in a phase 3 study.
The top pick and only the second drug to file for Emergency Use Authorization (EUA) during this pandemic is leronlimab. Filing a EUA means the drug company CytoDyn feels there is such a compelling case for approval of leronlimab that they are requesting the FDA to act now. It filed the request on August 17th and has received little to no fanfare from any of the major media outlets despite successfully reaching multiple endpoints in phase 2 clinical trial.
On the contrary, to great fanfare despite its shaky results, Gilead Sciences (GILD) was the first to file a EUA after it released “positive data” from the National Institute of Allergy and Infectious Diseases’ (NIAID) study of remdesivir for COVID-19. The EUA was controversial because Gilead changed the endpoints and although Gilead classified remdesivir as an antiviral, the drug had no impact on the viral load, no effect on mortality, and a relatively small reduction in hospital stay. Additionally, the safety profile is not optimal. Despite these shortcomings, it was approved on May 1st which was two days after the results were released.
From the above I think it is quite clear and as many others have stated as well, that Lobbyism is the biggest factor here in getting a drug to market.
Well done to Leo if he was the driving force in getting B tested in combo with Remdesivir. none of these treatments in the article have as far as I know been tested in combo with remdesivir, which gives B in combo a much better chance of getting to market.
Indeed, I see a few others came to that same conclusion as well, so many great minds.
LOL very funny
Lol I just posted the same before reading your post.
Maybe he meant this place.
https://veracerestaurant.com/
Great stuff! thanks JFM for all your info over the last few months.
It really helps with the patience here.
Insanity at its best
Total anarchy
Couldn't agree more, thanks
My take as well, it very much looks like success is at hand.
Great post, I hope you are right.
Yes the few, less than 900k dead, vast majority of them over 70 years old with on average 2.6 underlying health conditions.
The 900k is still less than the flu session 2017-2018 which killed 1,5 mil people
so yes the few, a pittance compared to how many will be killed in the coming depression, so if it is about saving lives, then who's lives are we saving?
Indeed, suicide and drug overdoses have gone up a lot and sure to go higher when all the handouts stops and people have no jobs. Current estimates points to 300 million jobs lost worldwide, I am sure all those people thinks they have done a great sacrifice to save the few.
I do indeed understand how the process works, please don't worry about that. The whole system is corrupt and lobbyism is running everything.
IPIX is battling hard against this preferential lobbyism selection process, Luckily B is so outstanding that IPIX still has a chance
Bunkers would probably be the answer :) I wish we could put some of the politicians in bunkers and keep them there for good.
The fact that B has not got a grant yet just show how corrupt the whole system is.
Please have a look at Armstrongeconomics.com just click on blog in order to read his latest post.
Martin Armstrong is in my view the best forecaster of the world, the movie The forecaster is about him and no surprise that it is banned in the US.
He writes mainly about the world economy and a bit less about Politics.
However as Covid entered he has written a lot about that and what is happening behind the scene.
He has had some amazing calls over the years and I am confident he knows exactly what is going on now.
That puts covid just under Kidney Disease and just above aids and preterm birth complications, so it should be at 13th place.
I like how they have lumped it in with Lower respiratory tract infection so that it is placed at 4th place
I wonder what the geniuses in government will do if a proper pandemic hits the world.
Fully agree, if just people were willing to open their eyes and compare the numbers, they would quickly realise what insanity is currently being played. That is not to take away from the fact that Covid might just have saved IPIX
Makes the lockdowns and total destruction of the world economy seem reasonable :)
Great post! Thanks
Alfasigma has some interest in Covid.
https://www.alfasigma.com/research/alfasigma-joins-the-global-fight-against-covid-19/
Their research and Innovation info. 5 ongoing projects in gastroenterology
https://www.alfasigma.com/research-innovation/
Sad but true
Thanks, great take on it. No doubt for me either that they will make some kind of offer.
A bidding war would be most welcome.
At $10 per share I am all aboard